A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations

Nikoletta Fotaki, A Aivaliotis, J Butler, J Dressman, M Fischbach, J Hempenstall, S Klein, C Reppas

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The importance of hydrodynamics in the development of in vitro-in vivo correlations (IVIVCs) for a BCS Class II compound housed in a hydrophilic matrix formulation and for a BCS Class I compound housed in an Osmotic Pump formulation was assessed. In vitro release data were collected in media simulating the fasted state conditions in the stomach, small intestine and the ascending colon using the USP II, the USP III and the USP IV release apparatuses. Using the data collected with the USP II apparatus, the plasma profiles were simulated and compared with human plasma profiles obtained after administration of the same dosage forms to healthy fasted volunteers. Data obtained with the USP III and USP IV apparatuses were directly correlated with the deconvoluted human plasma profiles. In vitro hydrodynamics affected the release profile from the hydrophilic matrix. For both formulations, based on the values of the difference factor, all three apparatuses were equally useful in predicting the actual in vivo profile on an average basis. Although some hydrodynamic variability is likely with low Solubility drugs in hydrophilic matrices, the hydrodynamics of USP II, III and IV may all be adequate as a starting point for generating IVIVCs for monolithic dosage forms in the fasted state.
Original languageEnglish
Pages (from-to)115-120
Number of pages6
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume73
Issue number1
Early online date11 May 2009
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Hydrodynamics
Dosage Forms
Ascending Colon
Solubility
Small Intestine
Stomach
Healthy Volunteers
In Vitro Techniques
Pharmaceutical Preparations

Cite this

A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations. / Fotaki, Nikoletta; Aivaliotis, A; Butler, J; Dressman, J; Fischbach, M; Hempenstall, J; Klein, S; Reppas, C.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 73, No. 1, 09.2009, p. 115-120.

Research output: Contribution to journalArticle

Fotaki, Nikoletta ; Aivaliotis, A ; Butler, J ; Dressman, J ; Fischbach, M ; Hempenstall, J ; Klein, S ; Reppas, C. / A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations. In: European Journal of Pharmaceutics and Biopharmaceutics. 2009 ; Vol. 73, No. 1. pp. 115-120.
@article{949365ffcb3e49b89eda8a686a48b7a0,
title = "A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations",
abstract = "The importance of hydrodynamics in the development of in vitro-in vivo correlations (IVIVCs) for a BCS Class II compound housed in a hydrophilic matrix formulation and for a BCS Class I compound housed in an Osmotic Pump formulation was assessed. In vitro release data were collected in media simulating the fasted state conditions in the stomach, small intestine and the ascending colon using the USP II, the USP III and the USP IV release apparatuses. Using the data collected with the USP II apparatus, the plasma profiles were simulated and compared with human plasma profiles obtained after administration of the same dosage forms to healthy fasted volunteers. Data obtained with the USP III and USP IV apparatuses were directly correlated with the deconvoluted human plasma profiles. In vitro hydrodynamics affected the release profile from the hydrophilic matrix. For both formulations, based on the values of the difference factor, all three apparatuses were equally useful in predicting the actual in vivo profile on an average basis. Although some hydrodynamic variability is likely with low Solubility drugs in hydrophilic matrices, the hydrodynamics of USP II, III and IV may all be adequate as a starting point for generating IVIVCs for monolithic dosage forms in the fasted state.",
author = "Nikoletta Fotaki and A Aivaliotis and J Butler and J Dressman and M Fischbach and J Hempenstall and S Klein and C Reppas",
year = "2009",
month = "9",
doi = "10.1016/j.ejpb.2009.04.012",
language = "English",
volume = "73",
pages = "115--120",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations

AU - Fotaki, Nikoletta

AU - Aivaliotis, A

AU - Butler, J

AU - Dressman, J

AU - Fischbach, M

AU - Hempenstall, J

AU - Klein, S

AU - Reppas, C

PY - 2009/9

Y1 - 2009/9

N2 - The importance of hydrodynamics in the development of in vitro-in vivo correlations (IVIVCs) for a BCS Class II compound housed in a hydrophilic matrix formulation and for a BCS Class I compound housed in an Osmotic Pump formulation was assessed. In vitro release data were collected in media simulating the fasted state conditions in the stomach, small intestine and the ascending colon using the USP II, the USP III and the USP IV release apparatuses. Using the data collected with the USP II apparatus, the plasma profiles were simulated and compared with human plasma profiles obtained after administration of the same dosage forms to healthy fasted volunteers. Data obtained with the USP III and USP IV apparatuses were directly correlated with the deconvoluted human plasma profiles. In vitro hydrodynamics affected the release profile from the hydrophilic matrix. For both formulations, based on the values of the difference factor, all three apparatuses were equally useful in predicting the actual in vivo profile on an average basis. Although some hydrodynamic variability is likely with low Solubility drugs in hydrophilic matrices, the hydrodynamics of USP II, III and IV may all be adequate as a starting point for generating IVIVCs for monolithic dosage forms in the fasted state.

AB - The importance of hydrodynamics in the development of in vitro-in vivo correlations (IVIVCs) for a BCS Class II compound housed in a hydrophilic matrix formulation and for a BCS Class I compound housed in an Osmotic Pump formulation was assessed. In vitro release data were collected in media simulating the fasted state conditions in the stomach, small intestine and the ascending colon using the USP II, the USP III and the USP IV release apparatuses. Using the data collected with the USP II apparatus, the plasma profiles were simulated and compared with human plasma profiles obtained after administration of the same dosage forms to healthy fasted volunteers. Data obtained with the USP III and USP IV apparatuses were directly correlated with the deconvoluted human plasma profiles. In vitro hydrodynamics affected the release profile from the hydrophilic matrix. For both formulations, based on the values of the difference factor, all three apparatuses were equally useful in predicting the actual in vivo profile on an average basis. Although some hydrodynamic variability is likely with low Solubility drugs in hydrophilic matrices, the hydrodynamics of USP II, III and IV may all be adequate as a starting point for generating IVIVCs for monolithic dosage forms in the fasted state.

UR - http://www.scopus.com/inward/record.url?scp=68349158943&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/j.ejpb.2009.04.012

U2 - 10.1016/j.ejpb.2009.04.012

DO - 10.1016/j.ejpb.2009.04.012

M3 - Article

VL - 73

SP - 115

EP - 120

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

IS - 1

ER -